2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Researchers Develop Analytical Pipeline to Identify ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

“The evidence would suggest that perhaps we need to investigate this pathway and perhaps this drug in both Parkinson’s, ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

BENGALURU: Parkinson’s disease (PD) has no cure, and the symptoms get worse as the disease progresses with the patient age.

The drug works by essentially forcing our cells to "spit out" dangerous protein clumps involved in Alzheimer's.

Generic net revenue increased by 9% to $427.35 million, driven by the strong performance of new product launches and ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

offering a new therapeutic target for Parkinson's and other movement ... Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may ...

Opens in a new tab or window Share on X ... The overall findings "suggest that perhaps we need to investigate this pathway, ...